Unknown PHASE3 INTERVENTIONAL 2-arm NCT05197088

Tamsulosin Assisted Ureteral Access Sheath Insertion

Medication Facilitated Ureteral Access Sheath Deployment During Ureteroscopy: the Impact of One Week of Pre-operative Tamsulosin

Sponsor: Sengkang General Hospital

Conditions Renal Stone Retrograde Intrarenal Surgery Urolithiasis

Interventions Tamsulosin

Updated 4 times since 2022 Last updated: Jan 9, 2022 Started: Jan 9, 2022 Primary completion: Mar 31, 2023 Completion: Jul 31, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05197088, this PHASE3 trial focuses on Renal Stone and Retrograde Intrarenal Surgery and remains ongoing. Sponsored by Sengkang General Hospital, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Feb 2024 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Not Yet Recruiting → Unknown Status
Feb 2022 — Feb 2024 [monthly]

Not Yet Recruiting PHASE3

First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sengkang General Hospital

Data source: Sengkang General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.